| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
A299480 Stock Overview
G&E Healthcare Co., Ltd. engages in online distribution of apparel.
G&E Healthcare Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩899.00 |
| 52 Week High | ₩2,250.00 |
| 52 Week Low | ₩766.00 |
| Beta | 0 |
| 1 Month Change | -18.27% |
| 3 Month Change | -21.49% |
| 1 Year Change | -43.64% |
| 3 Year Change | -58.28% |
| 5 Year Change | n/a |
| Change since IPO | -78.29% |
Recent News & Updates
Shareholder Returns
| A299480 | KR Retail Distributors | KR Market | |
|---|---|---|---|
| 7D | 0% | -5.6% | -1.8% |
| 1Y | -43.6% | -4.8% | -15.2% |
Return vs Industry: A299480 underperformed the KR Retail Distributors industry which returned -4.8% over the past year.
Return vs Market: A299480 underperformed the KR Market which returned -15.2% over the past year.
Price Volatility
| A299480 volatility | |
|---|---|
| A299480 Average Weekly Movement | 13.5% |
| Retail Distributors Industry Average Movement | 4.8% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 10.4% |
| 10% least volatile stocks in KR Market | 3.2% |
Stable Share Price: A299480 is more volatile than 90% of KR stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: A299480's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | https://www.hannahpad.com |
G&E Healthcare Co., Ltd. engages in online distribution of apparel. G&E Healthcare Co., Ltd. was formerly known as G&E Biotech Co., Ltd.
G&E Healthcare Fundamentals Summary
| A299480 fundamental statistics | |
|---|---|
| Market Cap | ₩9.98b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A299480 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A299480 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A299480 perform over the long term?
See historical performance and comparisonValuation
Is G&E Healthcare undervalued compared to its fair value and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
In this section, we usually try to help investors determine whether G&E Healthcare is trading at an attractive price based on the cash flow it is expected to produce in the future. But as G&E Healthcare has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
Future Growth
How is G&E Healthcare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
1.2%
Forecasted Retail industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as G&E Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has G&E Healthcare performed over the past 5 years?
Past Performance Score
0/6Past Performance Score 0/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
9.1%
Historical Retail annual earnings growth
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, G&E Healthcare has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Financial Health
How is G&E Healthcare's financial position?
Financial Health Score
0/6Financial Health Score 0/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
In this section we usually analyse G&E Healthcare's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. G&E Healthcare has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
Dividend
What is G&E Healthcare current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate A299480's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A299480's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if A299480's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A299480's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A299480 has not reported any payouts.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
CEO
G&E Healthcare has no CEO, or we have no data on them.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
G&E Healthcare Co., Ltd.'s employee growth, exchange listings and data sources
Key Information
- Name: G&E Healthcare Co., Ltd.
- Ticker: A299480
- Exchange: XKON
- Founded: NaN
- Industry: Distributors
- Sector: Retail
- Implied Market Cap: ₩9.980b
- Shares outstanding: 11.10m
- Website: https://www.hannahpad.com
Location
- G&E Healthcare Co., Ltd.
- 150 Jojeong-daero
- Hanam
- Gyeonggi-do
- 12930
- South Korea
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/05/15 00:00 |
| End of Day Share Price | 2022/05/14 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.